Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

AKRO Akero Therapeutics Inc

22,02

-0,09 (-0,41%)

08 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Akero Therapeutics (NASDAQ:AKRO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Akero Therapeutics Charts.

Akero Therapeutics (NASDAQ:AKRO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Akero Therapeutics Charts.

News Akero Therapeutics Inc

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
Dienstag 30 April 2024 (1 Woche vor) • GlobeNewswire Inc.

Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Freitag 8 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
Donnerstag 7 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Akero Therapeutics Announces Pricing of Public Offering of Common Stock
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

AMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on Disappointing Earnings, and Latest News
Dienstag 5 März 2024 (2 Monate vor) • IH Market News

Form 144 - Report of proposed sale of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Akero Therapeutics Inc News-Artikel

Deutsche Telekom

Financial Select Sector

Gold vs US Dollar

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen